Literature DB >> 35275607

Passive immunotherapies for COVID-19: The subtle line between standard and hyperimmune immunoglobulins is getting invisible.

Daniele Focosi1, Massimo Franchini2.   

Abstract

Entities:  

Keywords:  COVID19; SARS-CoV-2; immunosuppressants; intravenous immunoglobulins; polyclonal antibodies

Mesh:

Substances:

Year:  2022        PMID: 35275607     DOI: 10.1002/rmv.2341

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   11.043


× No keyword cloud information.
  2 in total

1.  Analysis of anti-Omicron neutralizing antibody titers in different convalescent plasma sources.

Authors:  Daniele Focosi; Massimo Franchini; Michael J Joyner; Arturo Casadevall; David J Sullivan
Journal:  medRxiv       Date:  2022-08-05

Review 2.  Intravenous immunoglobulin (IVIg) therapy in hospitalised adult COVID-19 patients: A systematic review and meta-analysis.

Authors:  Robert Marcec; Vinko Michael Dodig; Igor Radanovic; Robert Likic
Journal:  Rev Med Virol       Date:  2022-09-12       Impact factor: 11.043

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.